P13 Impact of ErbB Mutations on Clinical Outcomes in Afatinib- or Erlotinib-Treated Patients with SCC of the Lung
Bildiriler > Özet Bildiri
Yazarlar: G. Goss, M. Cobo, S. Lu, K. Syrigos, K.H. Lee, Ege Nazan TAVMERGEN GÖKER, V. Georgoulias, W. Li, D. Isla, J.M. Young, A. Morabito, S. Gadgeel, N. Gibson, N. Krämer, F. Solca, A. Cseh, E. Felip
Journal of Thoracic Oncology, , , Uluslararası, Özet Bildiri, Wos, cilt 13, ss S166-S166